SCHEMBL5752367

SCHEMBL5752367

O=C(O)C(Cc1cccc(OC(F)(F)C(F)F)c1)C(O)c1ccnc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CETP P11597 17/20 0.40
SLC1A1 P43005 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5751981 0.89 ALDH1A1 (0.39) CETP
SCHEMBL5751452 0.86 CETP (0.40) CETPSLC1A1
SCHEMBL5751829 0.85 CETP (0.49) CETPSLC1A1
SCHEMBL5752233 0.85 CETP (0.38) CETP
SCHEMBL7153377 0.85 CETP (0.38) CETP
SCHEMBL5751956 0.85 CETP (0.41) CETP
SCHEMBL5748762 0.84 CETP (0.46) CETPSLC1A1
SCHEMBL5752777 0.83 CETP (0.53) CETP
SCHEMBL5753040 0.82 ADRB3 (0.44) CETP
SCHEMBL5753856 0.82 CETP (0.40) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP CETP 1/4885SLC1A1 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.